Cancer-associated fibroblasts induce high mobility group box 1 and contribute to resistance to doxorubicin in breast cancer cells

Autophagy Inhibition Augments the Anticancer Effects of Epirubicin Treatment in Anthracycline-Sensitive and -Resistant Triple-Negative Breast Cancer

(2014) S. Chittaranjan et al.   CLINICAL CANCER RESEARCH

Fibroblasts Protect Melanoma Cells from the Cytotoxic Effects of Doxorubicin

(2014) Manoela Tiago et al.   TISSUE ENGINEERING PART A

Serum HMGB1 as a prognostic marker for malignant pleural mesothelioma

(2013) Chiharu Tabata et al.   BMC CANCER

Ovarian cancer microenvironment: implications for cancer dissemination and chemoresistance acquisition

(2013) Benoît Thibault et al.   CANCER AND METASTASIS REVIEWS

Breast stromal fibroblasts from histologically normal surgical margins are pro-carcinogenic

(2013) Maha A Al-Rakan et al.   JOURNAL OF PATHOLOGY

Adjuvant Systemic Therapies in Breast Cancer

(2013) Leonel F. Hernandez-Aya et al.   SURGICAL CLINICS OF NORTH AMERICA

The Role of Glycyrrhizin, an Inhibitor of HMGB1 Protein, in Anticancer Therapy

(2012) Ryszard Smolarczyk et al.   ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS

Stromal cells in tumor microenvironment and breast cancer

(2012) Yan Mao et al.   CANCER AND METASTASIS REVIEWS

Cancer Cell Secretion of the DAMP Protein HMGB1 Supports Progression in Malignant Mesothelioma

(2012) S. Jube et al.   CANCER RESEARCH

The Tumor Stroma as Mediator of Drug Resistance - A Potential Target to Improve Cancer Therapy?

(2012) Susanne Sebens et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

High mobility group box 1 released from necrotic cells enhances regrowth and metastasis of cancer cells that have survived chemotherapy

(2012) Yi Luo et al.   EUROPEAN JOURNAL OF CANCER

High-mobility group box 1 activates caspase-1 and promotes hepatocellular carcinoma invasiveness and metastases

(2012) Wei Yan et al.   HEPATOLOGY

Epithelial-mesenchymal transition in breast cancer correlates with high histological grade and triple-negative phenotype

(2012) Hoiseon Jeong et al.   HISTOPATHOLOGY

Implication of Tumor Microenvironment in Chemoresistance: Tumor-Associated Stromal Cells Protect Tumor Cells from Cell Death

(2012) Magali Castells et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

HMGB1 is overexpressed in tumor cells and promotes activity of regulatory T cells in patients with head and neck cancer

(2012) Clarissa A. Wild et al.   ORAL ONCOLOGY

Diagnostic Significance of Serum HMGB1 in Colorectal Carcinomas

(2012) Hanna Lee et al.   PLoS One

Circulating immunogenic cell death biomarkers HMGB1 and RAGE in breast cancer patients during neoadjuvant chemotherapy

(2012) Oliver J. Stoetzer et al.   TUMOR BIOLOGY

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Anti-estrogen resistance in breast cancer is induced by the tumor microenvironment and can be overcome by inhibiting mitochondrial function in epithelial cancer cells

(2011) Ubaldo E. Martinez-Outschoorn et al.   CANCER BIOLOGY & THERAPY

TNF-α induced secretion of HMGB1 from non-immune canine mammary epithelial cells (MTH53A)

(2011) Saskia Willenbrock et al.   CYTOKINE

DNA Alkylating Therapy Induces Tumor Regression through an HMGB1-Mediated Activation of Innate Immunity

(2011) J. L. Guerriero et al.   JOURNAL OF IMMUNOLOGY

HMGB1 and RAGE in Inflammation and Cancer

(2010) Gary P. Sims et al.   Annual Review of Immunology

DAMP-mediated autophagy contributes to drug resistance

(2010) Liying Liu et al.   Autophagy

Hmgb1 Promotes Wound Healing of 3T3 Mouse Fibroblasts via Rage-Dependent ERK1/2 Activation

(2010) Elia Ranzato et al.   CELL BIOCHEMISTRY AND BIOPHYSICS

HMGB-1 induces IL-6 production in human synovial fibroblasts through c-Src, Akt and NF-κB pathways

(2010) Chun-Han Hou et al.   JOURNAL OF CELLULAR PHYSIOLOGY

HMGB1-induced autophagy promotes chemotherapy resistance in leukemia cells

(2010) L Liu et al.   LEUKEMIA

Gene expression profiling of cholangiocarcinoma-derived fibroblast reveals alterations related to tumor progression and indicates periostin as a poor prognostic marker

(2010) Kusumawadee Utispan et al.   Molecular Cancer

Cancer associated fibroblasts (CAFs) in tumor microenvironment

(2009) Fei Xing   Frontiers in Bioscience-Landmark

The expression of HMGB1 protein and its receptor RAGE in human malignant tumors

(2009) Nora Kostova et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer

(2009) Pierre Farmer et al.   NATURE MEDICINE

Cancer associated fibroblasts in cancer pathogenesis

(2009) Omar E. Franco et al.   SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY

Epithelial-Mesenchymal Transition in Breast Cancer Relates to the Basal-like Phenotype

(2008) D. Sarrio et al.   CANCER RESEARCH

Role of myofibroblasts in innate chemoresistance of pancreatic carcinoma-Epigenetic downregulation of caspases

(2008) Susanne Sebens Müerköster et al.   INTERNATIONAL JOURNAL OF CANCER

Increased expression of high mobility group box 1 (HMGB1) is associated with progression and poor prognosis in human nasopharyngeal carcinoma

(2008) D Wu et al.   JOURNAL OF PATHOLOGY

Non-Hodgkin lymphoma expressing high levels of the danger-signalling protein HMGB1

(2008) Anke Meyer et al.   LEUKEMIA & LYMPHOMA